tiprankstipranks
Trending News
More News >
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market

Prelude Therapeutics (PRLD) Similar Stocks

Compare
169 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prelude Therapeutics
$2.19
$123.99M
-1.36
84.03%
0 Buy
0 Hold
0 Sell
Moderate Buy
Plus Therapeutics
$0.58
$75.43M
-0.29
-49.26%
3 Buy
0 Hold
0 Sell
Strong Buy
Repare Therapeutics
$2.17
$93.55M
-1.28
60.74%
1 Buy
1 Hold
0 Sell
Moderate Buy
PMV Pharmaceuticals
$1.22
$64.65M
-0.77
-17.35%
4 Buy
0 Hold
0 Sell
Strong Buy
Gain Therapeutics
$3.08
$118.46M
-4.82
93.71%
5 Buy
0 Hold
0 Sell
Strong Buy
Immix Biopharma
$4.32
$298.78M
-7.21
160.09%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRLD
Prelude Therapeutics
2.19
0.85
63.43%
PSTV
Plus Therapeutics
0.55
-0.61
-52.59%
RPTX
Repare Therapeutics
2.17
0.88
68.22%
PMVP
PMV Pharmaceuticals
1.22
-0.28
-18.67%
GANX
Gain Therapeutics
3.08
1.32
75.00%
IMMX
Immix Biopharma
5.67
3.43
153.12%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts